Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130175) titled 'Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Qian Feng
Condition:
Polymorphic Ventricular Tachycardia
Heart Failure
Intervention:
Device: Radiofrequency Catheter Ablation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 31, 2022
Target Sample Size: 118
Countries of Recruitment:
China
To know more, visit https://clinicaltrials...